These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 12649156)

  • 1. Proangiogenic properties of human myeloma cells: production of angiopoietin-1 and its potential relationship to myeloma-induced angiogenesis.
    Giuliani N; Colla S; Lazzaretti M; Sala R; Roti G; Mancini C; Bonomini S; Lunghi P; Hojden M; Genestreti G; Svaldi M; Coser P; Fattori PP; Sammarelli G; Gazzola GC; Bataille R; Almici C; Caramatti C; Mangoni L; Rizzoli V
    Blood; 2003 Jul; 102(2):638-45. PubMed ID: 12649156
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumor-derived vascular endothelial growth factor up-regulates angiopoietin-2 in host endothelium and destabilizes host vasculature, supporting angiogenesis in ovarian cancer.
    Zhang L; Yang N; Park JW; Katsaros D; Fracchioli S; Cao G; O'Brien-Jenkins A; Randall TC; Rubin SC; Coukos G
    Cancer Res; 2003 Jun; 63(12):3403-12. PubMed ID: 12810677
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potential role of the angiopoietin/tie2 system in ischemia-induced retinal neovascularization.
    Takagi H; Koyama S; Seike H; Oh H; Otani A; Matsumura M; Honda Y
    Invest Ophthalmol Vis Sci; 2003 Jan; 44(1):393-402. PubMed ID: 12506101
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of endothelial cell-associated molecules in AML cells.
    Watarai M; Miwa H; Shikami M; Sugamura K; Wakabayashi M; Satoh A; Tsuboi K; Imamura A; Mihara H; Katoh Y; Kita K; Nitta M
    Leukemia; 2002 Jan; 16(1):112-9. PubMed ID: 11840270
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Angiopoietin-1 inhibits vascular permeability, angiogenesis, and growth of hepatic colon cancer tumors.
    Stoeltzing O; Ahmad SA; Liu W; McCarty MF; Wey JS; Parikh AA; Fan F; Reinmuth N; Kawaguchi M; Bucana CD; Ellis LM
    Cancer Res; 2003 Jun; 63(12):3370-7. PubMed ID: 12810673
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of angiopoietin-2 and vascular endothelial growth factor in mice cerebral cortex after permanent focal cerebral ischemia.
    Wang RG; Zhu XZ
    Acta Pharmacol Sin; 2002 May; 23(5):405-11. PubMed ID: 11978190
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Angiopoietins and Tie-2 expression in angiogenesis and proliferation of human hepatocellular carcinoma.
    Mitsuhashi N; Shimizu H; Ohtsuka M; Wakabayashi Y; Ito H; Kimura F; Yoshidome H; Kato A; Nukui Y; Miyazaki M
    Hepatology; 2003 May; 37(5):1105-13. PubMed ID: 12717391
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modulation of the angiogenesis response through Ha-ras control, placenta growth factor, and angiopoietin expression in mouse skin carcinogenesis.
    Larcher F; Franco M; Bolontrade M; Rodriguez-Puebla M; Casanova L; Navarro M; Yancopoulos G; Jorcano JL; Conti CJ
    Mol Carcinog; 2003 Jun; 37(2):83-90. PubMed ID: 12766907
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Angiotensin AT(1) and AT(2) receptors differentially regulate angiopoietin-2 and vascular endothelial growth factor expression and angiogenesis by modulating heparin binding-epidermal growth factor (EGF)-mediated EGF receptor transactivation.
    Fujiyama S; Matsubara H; Nozawa Y; Maruyama K; Mori Y; Tsutsumi Y; Masaki H; Uchiyama Y; Koyama Y; Nose A; Iba O; Tateishi E; Ogata N; Jyo N; Higashiyama S; Iwasaka T
    Circ Res; 2001 Jan; 88(1):22-9. PubMed ID: 11139469
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human myeloma cells stimulate the receptor activator of nuclear factor-kappa B ligand (RANKL) in T lymphocytes: a potential role in multiple myeloma bone disease.
    Giuliani N; Colla S; Sala R; Moroni M; Lazzaretti M; La Monica S; Bonomini S; Hojden M; Sammarelli G; Barillè S; Bataille R; Rizzoli V
    Blood; 2002 Dec; 100(13):4615-21. PubMed ID: 12393684
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Complementary and coordinated roles of the VEGFs and angiopoietins during normal and pathologic vascular formation.
    Gale NW; Thurston G; Davis S; Wiegand SJ; Holash J; Rudge JS; Yancopoulos GD
    Cold Spring Harb Symp Quant Biol; 2002; 67():267-73. PubMed ID: 12858549
    [No Abstract]   [Full Text] [Related]  

  • 12. Angiopoietin-1 is inversely related to thymidine phosphorylase expression in human breast cancer, indicating a role in vascular remodeling.
    Currie MJ; Gunningham SP; Han C; Scott PA; Robinson BA; Harris AL; Fox SB
    Clin Cancer Res; 2001 Apr; 7(4):918-27. PubMed ID: 11309342
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tie2 ligands angiopoietin-1 and angiopoietin-2 are coexpressed with vascular endothelial cell growth factor in growing human bone.
    Horner A; Bord S; Kelsall AW; Coleman N; Compston JE
    Bone; 2001 Jan; 28(1):65-71. PubMed ID: 11165944
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of VEGF and angiopoietins-1 and -2 during ischemia-induced coronary angiogenesis.
    Matsunaga T; Warltier DC; Tessmer J; Weihrauch D; Simons M; Chilian WM
    Am J Physiol Heart Circ Physiol; 2003 Jul; 285(1):H352-8. PubMed ID: 12649074
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Angiopoietin-2 in Bone Marrow milieu promotes Multiple Myeloma-associated angiogenesis.
    Belloni D; Marcatti M; Ponzoni M; Ciceri F; Veschini L; Corti A; Caligaris Cappio F; Ferrarini M; Ferrero E
    Exp Cell Res; 2015 Jan; 330(1):1-12. PubMed ID: 25447443
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of the angiopoietins and their receptor Tie2 in human renal clear cell carcinomas; regulation by the von Hippel-Lindau gene and hypoxia.
    Currie MJ; Gunningham SP; Turner K; Han C; Scott PA; Robinson BA; Chong W; Harris AL; Fox SB
    J Pathol; 2002 Dec; 198(4):502-10. PubMed ID: 12434420
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selective functions of angiopoietins and vascular endothelial growth factor on blood vessels: the concept of "vascular domain".
    Sato TN; Loughna S; Davis EC; Visconti RP; Richardson CD
    Cold Spring Harb Symp Quant Biol; 2002; 67():171-80. PubMed ID: 12858538
    [No Abstract]   [Full Text] [Related]  

  • 18. Hypoxia-inducible factor-1 mediates activation of cultured vascular endothelial cells by inducing multiple angiogenic factors.
    Yamakawa M; Liu LX; Date T; Belanger AJ; Vincent KA; Akita GY; Kuriyama T; Cheng SH; Gregory RJ; Jiang C
    Circ Res; 2003 Oct; 93(7):664-73. PubMed ID: 12958144
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Angiogenesis in the human corpus luteum: localization and changes in angiopoietins, tie-2, and vascular endothelial growth factor messenger ribonucleic acid.
    Wulff C; Wilson H; Largue P; Duncan WC; Armstrong DG; Fraser HM
    J Clin Endocrinol Metab; 2000 Nov; 85(11):4302-9. PubMed ID: 11095472
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential inhibition of tumor angiogenesis by tie2 and vascular endothelial growth factor receptor-2 dominant-negative receptor mutants.
    Stratmann A; Acker T; Burger AM; Amann K; Risau W; Plate KH
    Int J Cancer; 2001 Feb; 91(3):273-82. PubMed ID: 11169947
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.